SANEMUS supports disruptive LFA technology

SANEMUS is pleased to support a promising start-up in its search for investors. The start-up is developing a groundbreaking platform technology that serves as a high-precision signal amplifier. The goal is to increase the sensitivity of lateral flow assays (LFAs) – known from rapid tests – by more than 100 times.

This technology opens up completely new applications for disposable, low-cost tests that were previously only possible with complex and expensive instruments. Particularly noteworthy is its compatibility with existing LFA platforms and read-out systems, which enables rapid market introduction with moderate investment requirements.

We are convinced of the potential of this solution and look forward to supporting the team on its path to successful financing and market development.

If you are interested in further information, please feel free to contact us.